You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 未名醫藥(002581.SZ)跌4% 2020年度預虧9976.23萬-19951.46萬元
格隆匯 01-29 10:57
格隆匯1月29日丨未名醫藥(002581.SZ)現報11.36元,跌3.97%,暫成交1億元,最新總市值74.9億元。未名醫藥昨日晚間公佈,預計2020年度歸屬於上市公司股東的淨虧損9976.23萬元-19951.46萬元,上年同期盈利6338.35萬元,扣除非經常性損益後的淨虧損8959.11萬元-17917.22萬元。由於國內各地區疫情階段性反覆,公司上下游企業復工緩慢,加之疫情影響導致各級醫療終端門診量減少,處方藥終端總體需求下降,同時受醫藥改革等宏觀政策、經濟下行等不利因素疊加,主營業務收入較上期有明顯減少。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account